Home > NRC Library > ADAMS Public Documents

License 07-27897-01 for Cardiac Diagnostic Ctr,authorizing use of byproduct matl listed in Group II of Schedule A of 10CFR35.100 for diagnostic procedures.

Accession Number: ML20212E204

Date Released: Tuesday, October 29, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20212E245 - Forwards License 07-27897-01. (2 page(s), 11/19/1986)
• ML20212E284 - Concurs w/statements & representations in 860909 application for license.Revised "Area Survey Procedures," reflecting revised protocol encl. (3 page(s), 10/22/1986)
• ML20212E379 - Requests addl info within 30 days of ltr date to continue review of 860909 application for license.Sager,not B Hammond should have signed application & should sign all future correspondence. (1 page(s), 10/17/1986)
• ML20212E425 - Advises that facility will perform nuclear cardiology studies exclusively & will not be involved in any other nuclear diagnostic testing. (1 page(s), 9/5/1986)
• ML20212E458 - Application for license,authorizing use of radioactive matl listed in Schedule A,Group II of 10CFR35.100.Fee paid. Supporting documentation encl. (39 page(s), 9/9/1986)
• ML20212E468 - Forwards addl fee for application for license. (1 page(s), 10/3/1986)
• ML20212E507 - Advises that addl fee required for 860905 application for license.Fee required prior to issuance of license. (2 page(s), 9/29/1986)